Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2782959 | 0.95 | CES2 (0.41) | FFAR4FFAR1LMNACES2CES1 | |
| SCHEMBL11529584 | 0.93 | CES2 (0.39) | FFAR4FFAR1FDPSLMNACES2 | |
| SCHEMBL10687004 | 0.91 | CES2 (0.41) | FFAR4FFAR1LMNACES2CES1 | |
| SCHEMBL10399823 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL21271848 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL10950789 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL11359540 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL9451147 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL8110729 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 | |
| SCHEMBL11864750 | 0.84 | FFAR4 (0.45) | FFAR4FFAR1SPHK1LMNACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7968607-B2 | Cosmetics 1-isostearylglycerol-3-Sulfate Sodium Salt, used for constriction of keratinocytes; aging resistance | KOA CORPORATION (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20060252946-A1 | Production process for glycidyl ether adduct and catalyst used for the process | KAO CORPORATION (JP) | 2006-11-09 | — | — | US | disclosed |
| EP-0512270-B1 | Cosmetic composition | KAO CORP (JP) | 1999-11-03 | — | — | EP | disclosed |
| US-5429820-A | A POLYOL GLYCERYL ETHER WHICH PROVIDES MOISTURIZING EFFECTS AND EXTENSIBILITY TO COSMETICS | KAO CORPORATION (JP) | 1995-07-04 | — | — | US | disclosed |
| EP-0512270-A2 | Cosmetic composition | KAO CORPORATION (JP) | 1992-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252946-A1 | Production process for glycidyl ether adduct and catalyst used for the process | AGL, GNMT, GMNN | FFAR4 2732/4885FFAR1 4375/4885FDPS 2082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.